Meeting Tue, 10/17/2023 - 12:00 Drug Prior Authorization Committee Meeting Information

Date
Media
Conduent Reports October 2023
Edit Implementation Schedule October 2023
New Drugs October 2023
PDL Announcements October 2023
PDL Recommendations October 2023
Pharmacy Advisory Boards Slides October 2023
Agenda
DPAC Agenda October 2023
Minutes
DPAC Minutes October 2023 Approved
Criteria
DUR Criteria
Old Business
Media
Neuromyelitis Optica Spectrum Disorder October 2023
C5 Complement Inhibitors October 2023
DUR Criteria
Clinical Edit Proposals – Existing Criteria
Media
Alpelisib October 2023
Emsam October 2023
Entresto October 2023
Immunoglobulins IVIG and SCIG October 2023
Narcolepsy Inhibitors October 2023
Nuedexta October 2023
Palforzia October 2023
Parathyroid Hormone and Bone Resorption Suppression Related Agents October 2023
Sickle Cell Disease October 2023
Spinal Muscular Atrophy October 2023
SSRI Step Therapy October 2023
Transthyretin Mediated Amyloidosis ATTR October 2023
Xcopri October 2023
DUR Criteria
Clinical Edit Proposals – New or Revised Criteria
Media
Botulinum Toxin October 2023
Diagnosis Code Required Policy October 2023
Enzyme Deficiency Select Agents October 2023
Generalized Myasthenia Gravis October 2023
Lambert Eaton Myasthenic Syndrome October 2023
Psychotropic Medications Polypharmacy October 2023
Ranolazine October 2023
RSV Prophylaxis Pediatric October 2023
Skyclarys October 2023
SNRI October 2023
Vyjuvek October 2023
DUR Criteria
Preferred Drug List Edit Proposals – Existing Criteria
Media
ACE Inhibitors CCB Combinations October 2023
ADHD Amphetamines Short Acting October 2023
ADHD Methylphenidate Short Acting October 2023
ADHD Non Stimulants October 2023
ARB CCB Combo October 2023
Anticonvulsants Rescue Agents October 2023
Antiplatelet Agents October 2023
BAB And Diuretic Combos October 2023
Bone Ossification Agents October 2023
CCBs Dihydropyridine October 2023
Direct Renin Inhibitors and Combos October 2023
Electrolyte Depleting Agents Phosphate Lowering October 2023
Niacin Derivatives October 2023
PCSK9 Inhibitors October 2023
PAH Agents ETRAs October 2023
PAH Agents PPAs Inhaled October 2023
PAH Agents PPAs Injectable October 2023
PAH Agents PPAs Oral October 2023
Triglyceride Lowering Agents October 2023
DUR Criteria
Preferred Drug List Edit Proposals – New or Revised Criteria
Media
ACE Inhibitors Diuretic Combos October 2023
ADHD Amphetamines Long Acting October 2023
ADHD Methylphenidate Long Acting October 2023
ARBs and ARB Diuretic Combos October 2023
Anticoagulants Oral and Subcutaneous October 2023
Antihyperuricemic Agents October 2023
Benign Prostatic Hyperplasia Agents October 2023
Beta Adrenergic Agents Short Acting October 2023
Bile Salt Agents October 2023
CCBs Non Dihydropyridine October 2023
Electrolyte Depleting Agents Potassium Lowering October 2023
HoFH Agents October 2023
Keratoconjunctivitis Agents October 2023
Mineralocorticoid Receptor Antagonists October 2023
Proton Pump Inhibitors October 2023
PAH Agents PDE5 and SGC Stimulators October 2023
Statins HMG CoA Reductase Inhibitors and Combos October 2023
Sympatholytics October 2023
Urea Cycle Disorder Agents October 2023
Page
Drug Prior Authorization Committee Meeting Information